Brooks W Morgan1, Trishul Siddharthan1, Matthew R Grigsby1, Suzanne L Pollard1, Robert Kalyesubula2, Robert A Wise1, Bruce Kirenga2, William Checkley3. 1. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Md. 2. Department of Medicine and Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda. 3. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Md; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Electronic address: wcheckl1@jhmi.edu.
Abstract
BACKGROUND: Allergic diseases are increasing in sub-Saharan Africa, but few studies have characterized the burden among adults. OBJECTIVE: We conducted a study to evaluate the prevalence and risk factors of allergic disorders in urban and rural Uganda. METHODS: We present a cross-sectional analysis of enrollment data from a population-based cohort study of adults aged ≥35 years in urban and rural Uganda. Sociodemographic and both lifetime and 12-month respiratory symptoms data were collected and spirometry was conducted following standard guidelines. RESULTS: In 1,308 adults (median age 43.8 years and 52.3% female), we found an age-adjusted prevalence of 6.8% for asthma (9.8% urban, 4.3% rural; P < .001), 11.9% for allergic rhinitis (16.4% urban, 7.8% rural; P < .001), and 8.2% for eczema (9.9% urban, 7.8% rural; P = .15). Urbanization was the primary driver of asthma, accounting for 61.4% of cases (95% confidence interval [CI] 22.0% to 83.4%), and was the strongest risk factor for any allergic illness (odds ratio [OR] = 1.87, 95% CI 1.39-2.51). Parental asthma was not associated with allergic illness. Asthma was associated with a lower forced expiratory volume in 1 second (FEV1) by 0.56 z scores (95% CI 0.33-0.80). We found a dose-response association between lower quintiles of the FEV1/forced vital capacity ratio and both hospitalization (OR = 1.77, 95% CI 1.21-2.59) and impairment in daily activities (1.65, 1.20-2.27). CONCLUSIONS: Asthma and allergic rhinitis were twice as prevalent in urban settings. Asthma was associated with greater impairment and worse lung function outcomes. We identified a high prevalence of allergic disorders in Uganda, which can be expected to increase due to urbanization and resultant exposures throughout early development.
BACKGROUND:Allergic diseases are increasing in sub-Saharan Africa, but few studies have characterized the burden among adults. OBJECTIVE: We conducted a study to evaluate the prevalence and risk factors of allergic disorders in urban and rural Uganda. METHODS: We present a cross-sectional analysis of enrollment data from a population-based cohort study of adults aged ≥35 years in urban and rural Uganda. Sociodemographic and both lifetime and 12-month respiratory symptoms data were collected and spirometry was conducted following standard guidelines. RESULTS: In 1,308 adults (median age 43.8 years and 52.3% female), we found an age-adjusted prevalence of 6.8% for asthma (9.8% urban, 4.3% rural; P < .001), 11.9% for allergic rhinitis (16.4% urban, 7.8% rural; P < .001), and 8.2% for eczema (9.9% urban, 7.8% rural; P = .15). Urbanization was the primary driver of asthma, accounting for 61.4% of cases (95% confidence interval [CI] 22.0% to 83.4%), and was the strongest risk factor for any allergic illness (odds ratio [OR] = 1.87, 95% CI 1.39-2.51). Parental asthma was not associated with allergic illness. Asthma was associated with a lower forced expiratory volume in 1 second (FEV1) by 0.56 z scores (95% CI 0.33-0.80). We found a dose-response association between lower quintiles of the FEV1/forced vital capacity ratio and both hospitalization (OR = 1.77, 95% CI 1.21-2.59) and impairment in daily activities (1.65, 1.20-2.27). CONCLUSIONS:Asthma and allergic rhinitis were twice as prevalent in urban settings. Asthma was associated with greater impairment and worse lung function outcomes. We identified a high prevalence of allergic disorders in Uganda, which can be expected to increase due to urbanization and resultant exposures throughout early development.
Authors: Lauren M Baumann; Colin L Robinson; Juan M Combe; Alfonso Gomez; Karina Romero; Robert H Gilman; Lilia Cabrera; Nadia N Hansel; Robert A Wise; Patrick N Breysse; Kathleen Barnes; Juan E Hernandez; William Checkley Journal: J Allergy Clin Immunol Date: 2011-01-14 Impact factor: 10.793
Authors: R I Ehrlich; D Du Toit; E Jordaan; M Zwarenstein; P Potter; J A Volmink; E Weinberg Journal: Am J Respir Crit Care Med Date: 1996-09 Impact factor: 21.405
Authors: Whitney D Arroyave; Felicia A Rabito; John C Carlson; Michelle L Sever; John Lefante Journal: Ann Allergy Asthma Immunol Date: 2015-11-07 Impact factor: 6.347
Authors: P Endara; M Vaca; T A E Platts-Mills; L Workman; M E Chico; M L Barreto; L C Rodrigues; P J Cooper Journal: Clin Exp Allergy Date: 2015-02 Impact factor: 5.018
Authors: Obianuju B Ozoh; Sunday A Aderibigbe; Adaeze C Ayuk; Olufemi O Desalu; Olufela E Oridota; Olajumoke Olufemi; Eruke Egbagbe; Musa Babashani; Azeezat Shopeyin; Kingsley Ukwaja; Sandra K Dede Journal: PLoS One Date: 2019-09-13 Impact factor: 3.240
Authors: Justice Moses K Aheto; Emilia A Udofia; Eugene Kallson; George Mensah; Minicuci Nadia; Naidoo Nirmala; Somnath Chatterji; Paul Kowal; Richard Biritwum; Alfred E Yawson Journal: PLoS One Date: 2020-12-09 Impact factor: 3.240
Authors: Olufemi O Desalu; Adekunle O Adeoti; Olutobi B Ojuawo; Adeniyi O Aladesanmi; Micheal S Oguntoye; Oluwafemi J Afolayan; Matthew O Bojuwoye; Ademola E Fawibe Journal: J Asthma Allergy Date: 2021-11-10
Authors: Trishul Siddharthan; Robert Kalyesubula; Brooks Morgan; Theresa Ermer; Tracy L Rabin; Alex Kayongo; Richard Munana; Nora Anton; Katharina Kast; Elke Schaeffner; Bruce Kirenga; Felix Knauf Journal: BMC Public Health Date: 2021-11-07 Impact factor: 3.295
Authors: Bruce J Kirenga; Levicatus Mugenyi; Corina de Jong; J Lucian Davis; Winceslaus Katagira; Thys van der Molen; Moses R Kamya; Marike Boezen Journal: Respir Res Date: 2018-09-21